REQUEST A DEMO
Total
USD $0.00
Search more companies

Diabetes Thyroid Hormone Research Institute Private Limited (India)

Main Activities: Securities and Commodity Contracts Intermediation and Brokerage
Full name: Diabetes Thyroid Hormone Research Institute Private Limited Profile Updated: November 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Diabetes Thyroid Hormone Research Institute Private Limited is an unlisted company, incorporated on 09/05/1996. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U67120MP1996PTC010807 and registration number is 010807.

Legal Address
207,B.C.M. Health Island,2Nd Floor Behind Bombay Hospital,Scheme No.54,
Indore; Madhya Pradesh; Postal Code: 452010

Contact Details: Purchase the Diabetes Thyroid Hormone Research Institute Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Diabetes Thyroid Hormone Research Institute Private Limited report to view the information.
Outstanding Shares:
Purchase the Diabetes Thyroid Hormone Research Institute Private Limited report to view the information.
Registered Capital:
Purchase the Diabetes Thyroid Hormone Research Institute Private Limited report to view the information.
Incorporation Date:
May 09, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Diabetes Thyroid Hormone Research Institute Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
7.51%
Total operating revenue
7.73%
Operating profit (EBIT)
-16.51%
EBITDA
-16.39%
Net Profit (Loss) for the Period
-90.55%
Total assets
-1.52%
Total equity
0.57%
Operating Profit Margin (ROS)
-0.8%
Net Profit Margin
-2.25%
Return on Equity (ROE)
-5.5%
Debt to Equity Ratio
2.45%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?